Old Web
English
Sign In
Acemap
>
authorDetail
>
Hajime Miyahara
Hajime Miyahara
GlaxoSmithKline
Albiglutide
Type 2 diabetes
Internal medicine
Medicine
Tolerability
3
Papers
66
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomized dose-finding study demonstrating the efficacy and tolerability of albiglutide in Japanese patients with type 2 diabetes mellitus
2014
Current Medical Research and Opinion
Yutaka Seino
Nobuya Inagaki
Hajime Miyahara
Inaha Okuda
Mark A. Bush
June Ye
M. Claire Holland
Susan L. Johnson
Eric Lewis
Hiromu Nakajima
Show All
Source
Cite
Save
Citations (25)
Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus
2009
Current Medical Research and Opinion
Yutaka Seino
Hiromu Nakajima
Hajime Miyahara
Takashi Kurita
Mark A. Bush
Fred Yang
Murray Stewart
Show All
Source
Cite
Save
Citations (40)
Safet and tolerability, pharmacokinetic and spharmacodynamics of albiglutide in Japanese subjects with type 2 diabetes: a comparison with an ethnically mixed population
2009
Canadian Journal of Diabetes
Yutaka Seino
Hiromu Nakajima
Hajime Miyahara
T. Kurita
Mark A. Bush
Fred Yang
Murray Stewart
Show All
Source
Cite
Save
Citations (1)
1